Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
1171.0000
-5.00
(
-0.43
%)
NSE
Aug 06, 2026
15:31 PM
52W Low on Jul 23, 2026
Volume:
1.3M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
08 May 2024
US FDA Approval
1171.00
-0.43%
Dr. Reddy Laboratories
Results Update:
Dr. Reddy's Laboratories Ltd.
by
SMC online
SMC online
Deven Choksey decreased Accumulate price target of Dr. Reddy's Laboratories Ltd. to 1291.0 on 24 Jul, 2026.
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market closes higher as easing oil prices and US-Iran talks boost sentiment
Trendlyne Marketwatch |
06 Aug 2026, 04:16PM
Five stocks to buy from analysts this week - August 4, 2026
The Baseline |
04 Aug 2026
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021